KYNB
Financials
- Market Capitalization 29.71 M
- Employee 34
- Founded 1993
- CEO N/A
- Website www.kyntrabio.com
- Headquarter California, United States
- FIGI BBG000FW5ZL6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4484 |  CRVO CervoMed Inc. - Common Stock | 3.31 USD | -7.28% | -5.43% | +32.40% | -53.64% | 30.65 M USD | ||
| 4493 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.96 USD | -6.80% | -11.93% | -1.03% | +0.84% | 29.90 M USD | ||
| 4504 |  PSTV PLUS THERAPEUTICS, Inc. - Common Stock | 4.17 USD | +4.25% | +3.73% | -18.40% | +1163.64% | 28.70 M USD | ||
| 4505 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.91 USD | -3.19% | -5.21% | -10.78% | -12.50% | 28.55 M USD |
Frequently asked questions about Kyntra Bio, Inc. - Common Stock
What is the Kyntra Bio, Inc. - Common Stock stock price today?
The current price of Kyntra Bio, Inc. - Common Stock (KYNB) is 7.34. Over the past 24 hours, the stock has changed by -4.80%. Follow the KYNB chart for real-time price dynamics.
What is the stock ticker of Kyntra Bio, Inc. - Common Stock?
Kyntra Bio, Inc. - Common Stock trades under the ticker KYNB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kyntra Bio, Inc. - Common Stock stock going up?
KYNB has changed by -1.87% over the last week, +4.11% over the last month, and -22.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kyntra Bio, Inc. - Common Stock net income for the last quarter?
Kyntra Bio, Inc. - Common Stock reported net income of -15.2 M for the last quarter. The previous quarter showed -14.22 M, which means net income changed by -6.88%.
How many employees does Kyntra Bio, Inc. - Common Stock have?
As of the latest available data, Kyntra Bio, Inc. - Common Stock has 34 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kyntra Bio, Inc. - Common Stock EBITDA?
Kyntra Bio, Inc. - Common Stock EBITDA is -13.99 M, and its EBITDA margin is -374.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kyntra Bio, Inc. - Common Stock stock?
You can buy Kyntra Bio, Inc. - Common Stock (KYNB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kyntra Bio, Inc. - Common Stock stock?
Investing in Kyntra Bio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYNB chart and related analysis on metatrader.com as part of your research.